What is the projected market valuation of the Mental Health Screening Market by 2035?

The projected market valuation for the Mental Health Screening Market is expected to reach 12.21 USD Billion by 2035. Read More

What was the market valuation of the Mental Health Screening Market in 2024?

The overall market valuation of the Mental Health Screening Market was 4.378 USD Billion in 2024. Read More

What is the expected CAGR for the Mental Health Screening Market during the forecast period 2025 - 2035?

The expected CAGR for the Mental Health Screening Market during the forecast period 2025 - 2035 is 9.77%. Read More

Which segment is projected to have the highest valuation in the Mental Health Screening Market by 2035?

The Self-Reported Questionnaires segment is projected to reach 4.2 USD Billion by 2035, indicating strong growth. Read More

How do healthcare providers contribute to the Mental Health Screening Market?

Healthcare providers are expected to account for a market valuation of 4.2 USD Billion by 2035, reflecting their significant role. Read More

What technologies are driving growth in the Mental Health Screening Market?

Telehealth platforms are projected to reach 4.2 USD Billion by 2035, showcasing their pivotal role in the market. Read More

Which disorder type is anticipated to dominate the Mental Health Screening Market by 2035?

Anxiety disorders are expected to dominate the market, with a projected valuation of 3.66 USD Billion by 2035. Read More

What role do key players like Optum and Talkspace play in the Mental Health Screening Market?

Key players such as Optum and Talkspace are instrumental in shaping the market landscape through innovative solutions. Read More

What is the expected growth trajectory for digital screening tools in the Mental Health Screening Market?

Digital screening tools are projected to grow to 2.2 USD Billion by 2035, indicating a shift towards technology-driven solutions. Read More

How do corporate organizations impact the Mental Health Screening Market?

Corporate organizations are expected to contribute a valuation of 2.3 USD Billion by 2035, highlighting their increasing focus on employee mental health. Read More

Mental Health Screening Market

ID: MRFR/HC/31516-HCR

128 Pages

Rahul Gotadki

Last Updated: May 15, 2026

Mental Health Screening Market Research Report: Size, Share, Trend Analysis By Screening Type (Self-Reported Questionnaires, Clinical Interviews, Physical Examinations, Digital Screening Tools), By End Users (Healthcare Providers, Educational Institutions, Corporate Organizations, Government Agencies), By Technology (Telehealth Platforms, Mobile Applications, Wearable Devices, Artificial Intelligence Tools), By Disorder Type (Anxiety Disorders, Mood Disorders, Personality Disorders, Psychotic Disorders) and By Regional (North America, Europe, South America, Asia Asia-Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Mental Health Screening Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)9.77%

2024 Market Size$ 4.38 Billion

2025 Market Size$ 4.81 Billion

2035 Market Size$ 12.21 Billion

Key Players

Pearson

Optum

Kaiser Permanente

Cerebral

Talkspace

Lyra Health

Trends

Integration of Technology in Screening Processes
Emphasis on Preventive Care
Increased Collaboration Among Stakeholders

Opportunities

Focus on Preventive Healthcare
Government Initiatives and Funding
Rising Awareness of Mental Health Issues

Summary Table of Contents Segmentation Methodology Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Screening Type (USD Billion)
  1. 4.1.1 Self-Reported Questionnaires
  2. 4.1.2 Clinical Interviews
  3. 4.1.3 Physical Examinations
  4. 4.1.4 Digital Screening Tools
2. 4.2 Healthcare, BY End User (USD Billion)
  1. 4.2.1 Healthcare Providers
  2. 4.2.2 Educational Institutions
  3. 4.2.3 Corporate Organizations
  4. 4.2.4 Government Agencies
3. 4.3 Healthcare, BY Technology (USD Billion)
  1. 4.3.1 Telehealth Platforms
  2. 4.3.2 Mobile Applications
  3. 4.3.3 Wearable Devices
  4. 4.3.4 Artificial Intelligence Tools
4. 4.4 Healthcare, BY Disorder Type (USD Billion)
  1. 4.4.1 Anxiety Disorders
  2. 4.4.2 Mood Disorders
  3. 4.4.3 Personality Disorders
  4. 4.4.4 Psychotic Disorders
5. 4.5 Healthcare, BY Region (USD Billion)
  1. 4.5.1 North America
    1. 4.5.1.1 US
    2. 4.5.1.2 Canada
  2. 4.5.2 Europe
    1. 4.5.2.1 Germany
    2. 4.5.2.2 UK
    3. 4.5.2.3 France
    4. 4.5.2.4 Russia
    5. 4.5.2.5 Italy
    6. 4.5.2.6 Spain
    7. 4.5.2.7 Rest of Europe
  3. 4.5.3 APAC
    1. 4.5.3.1 China
    2. 4.5.3.2 India
    3. 4.5.3.3 Japan
    4. 4.5.3.4 South Korea
    5. 4.5.3.5 Malaysia
    6. 4.5.3.6 Thailand
    7. 4.5.3.7 Indonesia
    8. 4.5.3.8 Rest of APAC
  4. 4.5.4 South America
    1. 4.5.4.1 Brazil
    2. 4.5.4.2 Mexico
    3. 4.5.4.3 Argentina
    4. 4.5.4.4 Rest of South America
  5. 4.5.5 MEA
    1. 4.5.5.1 GCC Countries
    2. 4.5.5.2 South Africa
    3. 4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Pearson (GB)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Optum (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Kaiser Permanente (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Cerebral (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Talkspace (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Lyra Health (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Mindstrong (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 BetterHelp (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Headspace Health (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY SCREENING TYPE
4. 6.4 US MARKET ANALYSIS BY END USER
5. 6.5 US MARKET ANALYSIS BY TECHNOLOGY
6. 6.6 US MARKET ANALYSIS BY DISORDER TYPE
7. 6.7 CANADA MARKET ANALYSIS BY SCREENING TYPE
8. 6.8 CANADA MARKET ANALYSIS BY END USER
9. 6.9 CANADA MARKET ANALYSIS BY TECHNOLOGY
10. 6.10 CANADA MARKET ANALYSIS BY DISORDER TYPE
11. 6.11 EUROPE MARKET ANALYSIS
12. 6.12 GERMANY MARKET ANALYSIS BY SCREENING TYPE
13. 6.13 GERMANY MARKET ANALYSIS BY END USER
14. 6.14 GERMANY MARKET ANALYSIS BY TECHNOLOGY
15. 6.15 GERMANY MARKET ANALYSIS BY DISORDER TYPE
16. 6.16 UK MARKET ANALYSIS BY SCREENING TYPE
17. 6.17 UK MARKET ANALYSIS BY END USER
18. 6.18 UK MARKET ANALYSIS BY TECHNOLOGY
19. 6.19 UK MARKET ANALYSIS BY DISORDER TYPE
20. 6.20 FRANCE MARKET ANALYSIS BY SCREENING TYPE
21. 6.21 FRANCE MARKET ANALYSIS BY END USER
22. 6.22 FRANCE MARKET ANALYSIS BY TECHNOLOGY
23. 6.23 FRANCE MARKET ANALYSIS BY DISORDER TYPE
24. 6.24 RUSSIA MARKET ANALYSIS BY SCREENING TYPE
25. 6.25 RUSSIA MARKET ANALYSIS BY END USER
26. 6.26 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
27. 6.27 RUSSIA MARKET ANALYSIS BY DISORDER TYPE
28. 6.28 ITALY MARKET ANALYSIS BY SCREENING TYPE
29. 6.29 ITALY MARKET ANALYSIS BY END USER
30. 6.30 ITALY MARKET ANALYSIS BY TECHNOLOGY
31. 6.31 ITALY MARKET ANALYSIS BY DISORDER TYPE
32. 6.32 SPAIN MARKET ANALYSIS BY SCREENING TYPE
33. 6.33 SPAIN MARKET ANALYSIS BY END USER
34. 6.34 SPAIN MARKET ANALYSIS BY TECHNOLOGY
35. 6.35 SPAIN MARKET ANALYSIS BY DISORDER TYPE
36. 6.36 REST OF EUROPE MARKET ANALYSIS BY SCREENING TYPE
37. 6.37 REST OF EUROPE MARKET ANALYSIS BY END USER
38. 6.38 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
39. 6.39 REST OF EUROPE MARKET ANALYSIS BY DISORDER TYPE
40. 6.40 APAC MARKET ANALYSIS
41. 6.41 CHINA MARKET ANALYSIS BY SCREENING TYPE
42. 6.42 CHINA MARKET ANALYSIS BY END USER
43. 6.43 CHINA MARKET ANALYSIS BY TECHNOLOGY
44. 6.44 CHINA MARKET ANALYSIS BY DISORDER TYPE
45. 6.45 INDIA MARKET ANALYSIS BY SCREENING TYPE
46. 6.46 INDIA MARKET ANALYSIS BY END USER
47. 6.47 INDIA MARKET ANALYSIS BY TECHNOLOGY
48. 6.48 INDIA MARKET ANALYSIS BY DISORDER TYPE
49. 6.49 JAPAN MARKET ANALYSIS BY SCREENING TYPE
50. 6.50 JAPAN MARKET ANALYSIS BY END USER
51. 6.51 JAPAN MARKET ANALYSIS BY TECHNOLOGY
52. 6.52 JAPAN MARKET ANALYSIS BY DISORDER TYPE
53. 6.53 SOUTH KOREA MARKET ANALYSIS BY SCREENING TYPE
54. 6.54 SOUTH KOREA MARKET ANALYSIS BY END USER
55. 6.55 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
56. 6.56 SOUTH KOREA MARKET ANALYSIS BY DISORDER TYPE
57. 6.57 MALAYSIA MARKET ANALYSIS BY SCREENING TYPE
58. 6.58 MALAYSIA MARKET ANALYSIS BY END USER
59. 6.59 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
60. 6.60 MALAYSIA MARKET ANALYSIS BY DISORDER TYPE
61. 6.61 THAILAND MARKET ANALYSIS BY SCREENING TYPE
62. 6.62 THAILAND MARKET ANALYSIS BY END USER
63. 6.63 THAILAND MARKET ANALYSIS BY TECHNOLOGY
64. 6.64 THAILAND MARKET ANALYSIS BY DISORDER TYPE
65. 6.65 INDONESIA MARKET ANALYSIS BY SCREENING TYPE
66. 6.66 INDONESIA MARKET ANALYSIS BY END USER
67. 6.67 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
68. 6.68 INDONESIA MARKET ANALYSIS BY DISORDER TYPE
69. 6.69 REST OF APAC MARKET ANALYSIS BY SCREENING TYPE
70. 6.70 REST OF APAC MARKET ANALYSIS BY END USER
71. 6.71 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
72. 6.72 REST OF APAC MARKET ANALYSIS BY DISORDER TYPE
73. 6.73 SOUTH AMERICA MARKET ANALYSIS
74. 6.74 BRAZIL MARKET ANALYSIS BY SCREENING TYPE
75. 6.75 BRAZIL MARKET ANALYSIS BY END USER
76. 6.76 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
77. 6.77 BRAZIL MARKET ANALYSIS BY DISORDER TYPE
78. 6.78 MEXICO MARKET ANALYSIS BY SCREENING TYPE
79. 6.79 MEXICO MARKET ANALYSIS BY END USER
80. 6.80 MEXICO MARKET ANALYSIS BY TECHNOLOGY
81. 6.81 MEXICO MARKET ANALYSIS BY DISORDER TYPE
82. 6.82 ARGENTINA MARKET ANALYSIS BY SCREENING TYPE
83. 6.83 ARGENTINA MARKET ANALYSIS BY END USER
84. 6.84 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
85. 6.85 ARGENTINA MARKET ANALYSIS BY DISORDER TYPE
86. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY SCREENING TYPE
87. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
88. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
89. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISORDER TYPE
90. 6.90 MEA MARKET ANALYSIS
91. 6.91 GCC COUNTRIES MARKET ANALYSIS BY SCREENING TYPE
92. 6.92 GCC COUNTRIES MARKET ANALYSIS BY END USER
93. 6.93 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
94. 6.94 GCC COUNTRIES MARKET ANALYSIS BY DISORDER TYPE
95. 6.95 SOUTH AFRICA MARKET ANALYSIS BY SCREENING TYPE
96. 6.96 SOUTH AFRICA MARKET ANALYSIS BY END USER
97. 6.97 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
98. 6.98 SOUTH AFRICA MARKET ANALYSIS BY DISORDER TYPE
99. 6.99 REST OF MEA MARKET ANALYSIS BY SCREENING TYPE
100. 6.100 REST OF MEA MARKET ANALYSIS BY END USER
101. 6.101 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
102. 6.102 REST OF MEA MARKET ANALYSIS BY DISORDER TYPE
103. 6.103 KEY BUYING CRITERIA OF HEALTHCARE
104. 6.104 RESEARCH PROCESS OF MRFR
105. 6.105 DRO ANALYSIS OF HEALTHCARE
106. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
107. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
108. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
109. 6.109 HEALTHCARE, BY SCREENING TYPE, 2024 (% SHARE)
110. 6.110 HEALTHCARE, BY SCREENING TYPE, 2024 TO 2035 (USD Billion)
111. 6.111 HEALTHCARE, BY END USER, 2024 (% SHARE)
112. 6.112 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
113. 6.113 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
114. 6.114 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
115. 6.115 HEALTHCARE, BY DISORDER TYPE, 2024 (% SHARE)
116. 6.116 HEALTHCARE, BY DISORDER TYPE, 2024 TO 2035 (USD Billion)
117. 6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.2.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.3.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.3.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.4.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.4.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.5.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.5.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.6.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.6.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.7.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.7.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.8.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.8.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.9.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.9.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.10.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.10.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.11.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.11.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.12.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.12.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.13.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.13.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.14.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.14.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.15.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.15.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.16.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.16.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.17.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.17.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.18.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.18.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.19.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.19.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.20.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.20.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.21.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.21.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.22.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.22.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.23.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.23.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.24.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.24.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.25.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.25.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.26.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.26.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.27.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.27.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.28.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.28.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.29.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.29.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY SCREENING TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY END USER, 2025-2035 (USD Billion)
  3. 7.30.3 BY TECHNOLOGY, 2025-2035 (USD Billion)
  4. 7.30.4 BY DISORDER TYPE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Mental Health Screening Market Segmentation

Mental Health Screening Market By Screening Type (USD Billion, 2025-2035)

Self-Reported Questionnaires
Clinical Interviews
Physical Examinations
Digital Screening Tools

Mental Health Screening Market By End User (USD Billion, 2025-2035)

Mental Health Screening Market Providers
Educational Institutions
Corporate Organizations
Government Agencies

Mental Health Screening Market By Mental Health Screening Market (USD Billion, 2025-2035)

Telehealth Platforms
Mobile Applications
Wearable Devices
Artificial Intelligence Tools

Mental Health Screening Market By Disorder Type (USD Billion, 2025-2035)

Anxiety Disorders
Mood Disorders
Personality Disorders
Psychotic Disorders

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”